articles for l i r n e n e t regulatory resources

1. SUMMArY Monoclonal antibodies targeted against the proprotein convertase subtilisin kexin type 9 (PCSK9) protein increase the liver’s ability to remove low-density lipop...

https://www.cadth.ca/pcsk9-inhibitor-monoclonal-antibodies-treatment-hypercholesterolemia